| scholarly article | Q13442814 |
| P2093 | author name string | Yuan Yuan | |
| Ye Wu | |||
| Jie Min | |||
| Di Tian | |||
| Chang Ge | |||
| Dian Zhou | |||
| Jinping Shu | |||
| P2860 | cites work | Interleukin-22 receptor 1 upregulation and activation in hypoxic endothelial cells improves perfusion recovery in experimental peripheral arterial disease | Q91593999 |
| Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma | Q92989291 | ||
| Hepatocellular Carcinoma | Q93002915 | ||
| Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice | Q93195686 | ||
| Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor | Q24290133 | ||
| Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis | Q26825858 | ||
| Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease | Q27027380 | ||
| Liver sinusoidal endothelial cells and liver regeneration | Q27027903 | ||
| IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes | Q28200354 | ||
| Recent advances in hepatocellular carcinoma therapy | Q30236010 | ||
| Evolving therapies for liver fibrosis | Q30539166 | ||
| Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. | Q30847275 | ||
| IL-22 is involved in liver regeneration after hepatectomy | Q33589028 | ||
| New drug targets for alcoholic liver disease | Q33746508 | ||
| Combination therapy: New hope for alcoholic hepatitis? | Q33746519 | ||
| Acute and chronic effects of IL-22 on acetaminophen-induced liver injury | Q34054086 | ||
| Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3 | Q34163926 | ||
| In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression | Q35074604 | ||
| IL22/IL-22R pathway induces cell survival in human glioblastoma cells | Q35203455 | ||
| A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus | Q35420938 | ||
| Interleukin-22: immunobiology and pathology | Q35530956 | ||
| Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease | Q35762773 | ||
| Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection | Q35833796 | ||
| Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword | Q35906051 | ||
| Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection | Q36062404 | ||
| Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice | Q36089631 | ||
| Interleukin-22 contributes to liver regeneration in mice with concanavalin A-induced hepatitis after hepatectomy | Q36501689 | ||
| The global burden of liver disease: the major impact of China | Q36901892 | ||
| Liver regeneration: alternative epithelial pathways | Q37605282 | ||
| Liver stem/progenitor cells: their characteristics and regulatory mechanisms | Q37827017 | ||
| IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration | Q38079587 | ||
| Differentiation of progenitors in the liver: a matter of local choice | Q38103361 | ||
| Therapeutic opportunities of the IL-22-IL-22R1 system | Q38174792 | ||
| Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. | Q38344139 | ||
| New trends on obesity and NAFLD in Asia | Q38667832 | ||
| Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | Q38698442 | ||
| Interleukin 32, inflammation and cancer | Q38754758 | ||
| Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C. | Q38900038 | ||
| Hepatostat: Liver regeneration and normal liver tissue maintenance | Q39044713 | ||
| Lipid droplets and liver disease: from basic biology to clinical implications. | Q39253589 | ||
| The role of interleukin-22 in hepatitis C virus infection | Q40025870 | ||
| IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro | Q40186472 | ||
| Hepatic stellate cells as key target in liver fibrosis | Q40200602 | ||
| Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation | Q40560155 | ||
| Critical Role of IL-22/IL22-RA1 Signaling in Pneumococcal Pneumonia | Q40600498 | ||
| Up-regulated Reg proteins induced by Interleukin-22 treatment ameliorate acute liver injury in rat model | Q41416579 | ||
| IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections. | Q41616535 | ||
| Pathogenesis of Alcoholic Liver Disease | Q41983037 | ||
| The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine. | Q42512933 | ||
| Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma | Q43782860 | ||
| IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver | Q45363028 | ||
| Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice | Q46123016 | ||
| Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes | Q46323162 | ||
| Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. | Q46742099 | ||
| A decade of progress in liver regenerative medicine | Q47222178 | ||
| The immunology of hepatocellular carcinoma | Q47548125 | ||
| Interleukin-22 in human inflammatory diseases and viral infections | Q47610663 | ||
| A catch-22: Interleukin-22 and cancer | Q48231667 | ||
| Psoriasis: A STAT3-Centric View | Q48278607 | ||
| Role of inflammatory response in liver diseases: Therapeutic strategies | Q48513535 | ||
| Hepatic Progenitor Cells: An Update. | Q52649604 | ||
| Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects. | Q53072969 | ||
| The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. | Q53136381 | ||
| Interleukin-22 and Chemokine Interferon γ -Inducible-10 (IP-10) Levels in Chronic Hepatitis C Patients and Treatment Response to Pegylated Interferon and Ribavirin Therapy. | Q54257996 | ||
| Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection | Q58118313 | ||
| Blueberry, combined with probiotics, alleviates non-alcoholic fatty liver disease via IL-22-mediated JAK1/STAT3/BAX signaling | Q58564395 | ||
| Chronic hepatitis B virus infection | Q59349588 | ||
| P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration | Q60220469 | ||
| Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin | Q60630406 | ||
| Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy. | Q64916170 | ||
| Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. | Q64976206 | ||
| Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection | Q83066590 | ||
| Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 | Q84365414 | ||
| Cyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in mice | Q85830613 | ||
| Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies | Q87589742 | ||
| STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis | Q88641525 | ||
| Interleukin-22 from bench to bedside: a promising drug for epithelial repair | Q89158646 | ||
| Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine | Q89426996 | ||
| The balancing act of the liver: tissue regeneration versus fibrosis | Q89769221 | ||
| Evolution of efficacious pangenotypic hepatitis C virus therapies | Q90169046 | ||
| Targeting the IL-22/IL-22BP axis enhances tight junctions and reduces inflammation during influenza infection | Q90617558 | ||
| Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways | Q90719600 | ||
| Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease | Q90979288 | ||
| Interleukin-22 Ameliorates Neutrophil-Driven Nonalcoholic Steatohepatitis Through Multiple Targets | Q91204508 | ||
| An Open Label, Dose Escalation Study To Assess The Safety And Efficacy Of IL-22 Agonist F-652 In Patients With Alcoholic Hepatitis | Q91487288 | ||
| Tissue Repair in the Mouse Liver Following Acute Carbon Tetrachloride Depends on Injury-Induced Wnt/β-Catenin Signaling | Q91575269 | ||
| P433 | issue | 13 | |
| P304 | page(s) | 2405-2413 | |
| P577 | publication date | 2020-06-29 | |
| P1433 | published in | International Journal of Biological Sciences | Q6051326 |
| P1476 | title | Interleukin 22 in Liver Injury, Inflammation and Cancer | |
| P478 | volume | 16 |
Search more.